RGEN.NASDAQRepligen CORP

Form 4: Repligen CEO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Olivier Loeillot, Chief Executive Officer and a Director of Repligen Corp, sold 5,535 shares of common stock on October 5, 2026.

Summary

  • Open-market sale: disposed of 1,333 Common Stock at $178.75 ($238,274) on October 5, 2026; holds 45,788 after (Direct).
  • Option exercise/conversion: acquired 4,202 Common Stock at $154.96 ($651,142) on October 5, 2026; holds 49,990 after (Direct).
  • Open-market sale: disposed of 4,202 Common Stock at $190.00 ($798,380) on October 5, 2026; holds 45,788 after (Direct).
  • Option exercise/conversion: disposed of 4,202 Stock Option (Right to Buy) on October 5, 2026; holds 8,405 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,036,654 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Olivier Loeillot — Director, Officer (Chief Executive Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-10-05Open-market saleCommon Stock1,333$179$238.3K45,788
2026-10-05Option exercise/conversionCommon Stock4,202$155$651.1K49,990
2026-10-05Open-market saleCommon Stock4,202$190$798.4K45,788
2026-10-05Option exercise/conversionStock Option (Right to Buy)4,202——8,405

Key Dates

DateDescription
2026-10-05Open-market sale (1,333 shares)
2026-10-05Option exercise/conversion (4,202 shares)
2026-10-05Open-market sale (4,202 shares)
2026-10-05Option exercise/conversion (4,202 shares)

Keywords

insider transaction, Form 4, RGEN, REPLIGEN CORP, bearish, Olivier Loeillot

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.